Cargando…
PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429355/ http://dx.doi.org/10.1097/01.HS9.0000975620.07810.a6 |
| _version_ | 1785090691978756096 |
|---|---|
| author | Krecak, Ivan Pivac, Ljerka Cubric, Eva Lucijanic, Marko Skelin, Marko |
| author_facet | Krecak, Ivan Pivac, Ljerka Cubric, Eva Lucijanic, Marko Skelin, Marko |
| author_sort | Krecak, Ivan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104293552023-08-17 PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS Krecak, Ivan Pivac, Ljerka Cubric, Eva Lucijanic, Marko Skelin, Marko Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429355/ http://dx.doi.org/10.1097/01.HS9.0000975620.07810.a6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Krecak, Ivan Pivac, Ljerka Cubric, Eva Lucijanic, Marko Skelin, Marko PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title | PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title_full | PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title_fullStr | PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title_full_unstemmed | PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title_short | PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| title_sort | pb2219: polypharmacy and drug-to-drug interactions may have a negative effect on survival in patients with chronic myeloproliferative neoplasms |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429355/ http://dx.doi.org/10.1097/01.HS9.0000975620.07810.a6 |
| work_keys_str_mv | AT krecakivan pb2219polypharmacyanddrugtodruginteractionsmayhaveanegativeeffectonsurvivalinpatientswithchronicmyeloproliferativeneoplasms AT pivacljerka pb2219polypharmacyanddrugtodruginteractionsmayhaveanegativeeffectonsurvivalinpatientswithchronicmyeloproliferativeneoplasms AT cubriceva pb2219polypharmacyanddrugtodruginteractionsmayhaveanegativeeffectonsurvivalinpatientswithchronicmyeloproliferativeneoplasms AT lucijanicmarko pb2219polypharmacyanddrugtodruginteractionsmayhaveanegativeeffectonsurvivalinpatientswithchronicmyeloproliferativeneoplasms AT skelinmarko pb2219polypharmacyanddrugtodruginteractionsmayhaveanegativeeffectonsurvivalinpatientswithchronicmyeloproliferativeneoplasms |